Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Evidence for a membrane surface defect in erythrocytes in Huntington's disease

Producción científica: Articlerevisión exhaustiva

19 Citas (Scopus)

Resumen

Electron spin resonance studies of erythrocyte membranes from patients with Huntington's disease and normal controls have been performed. Intact erythrocytes in each case were either untreated or subjected to proteolysis with the membrane impermeable enzymes, pronase, chymotrypsin, or trypsin. Membrane ghosts were prepared from untreated and protease-treated intact cells and spin labeled with protein- or lipid-specific spin probes. Comparison of the resulting electron spin resonance spectra confirmed our previous findings that in untreated samples the relevant parameter of the protein-specific spin label was increased in Huntington's disease (P < 0.02) suggesting an altered physical state of membrane proteins in this disorder, while no difference in erythrocyte lipid fluidity could be discerned. No significant difference in the physical state of membrane proteins in Huntington's disease and control as judged as spin labeling methods could be detemined in membrane ghosts prepared from protease-treated intact cells. These results, together with the known specificity of the proteases used in this study, suggest that a molecular defect in Huntington's disease erythrocytes is manifested in an exterior part of a membrane protein and supports our hypothesis that Huntington's disease is associated with a generalized cell membrane defect.

Idioma originalEnglish
Páginas (desde-hasta)609-615
Número de páginas7
PublicaciónLife Sciences
Volumen27
N.º7
DOI
EstadoPublished - 1980

Nota bibliográfica

Funding Information:
work was supported in part by grants from the National Institutes of Health (NS-13791-03, D.A.B. and W.R.M.), (NS-14221, W.R.M.) and the Muscular Dystorphy Association of America (D.A.B.)

Financiación

work was supported in part by grants from the National Institutes of Health (NS-13791-03, D.A.B. and W.R.M.), (NS-14221, W.R.M.) and the Muscular Dystorphy Association of America (D.A.B.)

FinanciadoresNúmero del financiador
Muscular Dystorphy Association of America
National Institutes of Health (NIH)NS-14221, NS-13791-03

    ASJC Scopus subject areas

    • General Pharmacology, Toxicology and Pharmaceutics
    • General Biochemistry, Genetics and Molecular Biology

    Huella

    Profundice en los temas de investigación de 'Evidence for a membrane surface defect in erythrocytes in Huntington's disease'. En conjunto forman una huella única.

    Citar esto